Tango Therapeutics Inc. (TNGX)
2.75
0.13 (4.96%)
At close: Jan 15, 2025, 3:59 PM
2.62
-4.55%
After-hours Jan 15, 2025, 04:15 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -101.74M | -108.18M | -58.23M | -51.97M | -14.10M |
| Depreciation & Amortization | 2.42M | 1.61M | 897.00K | 718.00K | 643.00K |
| Stock-Based Compensation | 19.08M | 14.23M | 7.83M | 1.76M | 1.69M |
| Other Working Capital | -38.26M | -19.59M | -12.58M | 119.08M | 1.70M |
| Other Non-Cash Items | 234.00K | 1.75M | 1.32M | 890.00K | -14.74M |
| Deferred Income Tax | n/a | n/a | n/a | n/a | n/a |
| Change in Working Capital | -37.97M | -18.49M | -11.35M | 118.67M | 1.70M |
| Operating Cash Flow | -117.98M | -109.08M | -59.53M | 70.07M | -24.80M |
| Capital Expenditures | -1.53M | -7.69M | -1.84M | -1.11M | -1.82M |
| Acquisitions | n/a | -34.09M | 181.60M | n/a | n/a |
| Purchase of Investments | -310.57M | -208.50M | -372.36M | -207.54M | n/a |
| Sales Maturities Of Investments | 353.53M | 242.59M | 190.76M | 63.22M | n/a |
| Other Investing Acitivies | n/a | 34.09M | -181.60M | -40.00K | 2.67M |
| Investing Cash Flow | 41.43M | 26.40M | -183.43M | -145.47M | 848.00K |
| Debt Repayment | n/a | n/a | 342.11M | n/a | n/a |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 2.39M | 1.61M | 15.21M | 80.88M | 11.00M |
| Financial Cash Flow | 82.41M | 1.61M | 357.32M | 80.88M | 11.00M |
| Net Cash Flow | 5.85M | -81.07M | 114.36M | 5.49M | 25.17M |
| Free Cash Flow | -119.51M | -116.77M | -61.36M | 68.97M | -26.62M |